

Against the Monopoly on Hiv/Aids Drugs
Public health and HIV/AIDS activists from the developing world are seeking to break the monopoly over drugs held by pharmaceutical giants through a new global campaign designed to influence international debate over the issue. Formulated at the end of a three-day meeting, which brought some 200 participants from 20 countries to Thailand’s capital, the campaign seeks ‘’a new way out of the current patent system; one that will encourage innovation of new drugs and access for all,’’ says one of the organizers of the International Conference on Compulsory Licensing: Innovation and Access for All. ‘’What we have now is innovation controlled by the pharmaceutical industry that allows them to have a monopoly on drugs.’’





